Tuya Director Sidney Xuande Sale Sparks Investor Debate
A Tuya insider sale by tuya director sidney xuande drew market attention. This article explains what the move signals...
Articles — Page 258
Astera Labs Stock Skyrocketed: What Sparked the Rally
Astera Labs stock skyrocketed last month as multiple catalysts converged. This deep-dive breaks down the driving forc...
Abbott Labs Glaukos: Which Stock Is Best to Buy in 2026
In 2026, two very different healthcare players—Abbott Laboratories and Glaukos—offer contrasting paths to potential g...
Don't UnitedHealth Group (UNH) Stock: A Practical Guide
Thinking about UnitedHealth Group stock? This guide shows practical reasons to pause, key risks to watch, and smarter...
Vanguard Long-Term Treasury IShares: Safety and Returns in One Bond Fund
Two popular bond funds target different corners of the fixed-income market. This guide breaks down how Vanguard Long-...
Tavia Hunt Pushes Back Amid Celebrity Wedding Rumors
Online chatter can threaten more than reputations; it can touch family budgets and financial security. This piece exp...
Shawn Johnson’s Video with: Online Moments, Family Finances
A lighthearted moment on camera can ripple into budgets, brand deals, and privacy tradeoffs. Here’s how Shawn Johnson...
Sen. Wyden Urges Senate to Preserve Blockchain Protections
Sen. Ron Wyden is pushing Senate leadership to retain protections for blockchain developers in a sweeping crypto bill...
Synergy Take Over Newrez Reshapes Retail Mortgage Market
Synergy One Lending will absorb Newrez's distributed retail mortgage operations under a strategic agreement, extendin...
Beazer Fight Over Standstill Intensifies as Bid Climbs
Beazer Homes faces a pivotal moment as Dream Finders increases its cash bid to $32 per share, intensifying the beazer...
Dentists Retire Rich Stay: The Cash-Balance Plan Edge
A growing cohort of dentists is turning to cash-balance plans to fund retirement beyond 401(k) limits, giving practic...
Office Conversions Face Scrutiny After Pfizer HQ Incident
A buckling-column episode at the former Pfizer headquarters triggers renewed scrutiny of NYC office-to-residential pr...